Actively Recruiting
Evaluation of a New Total-Body PET Scanner for Cancer Imaging Quality Improvement Study Using Biograph Vision Quadra in Lung, Head and Neck, and Prostate Cancer
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-10-09
90
Participants Needed
7
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new total-body PET scanner called the Biograph Vision Quadra for people with cancer. The goal is to determine if this scanner produces better PETCT images and provides more useful imaging information than standard PETCT scanners. This study is a quality improvement protocol focused on advanced imaging performance for patients with lung, head and neck, or prostate cancer. Participants will undergo one or two additional scans using the Biograph Vision Quadra scanner alongside their planned PETCT scans performed as part of standard care or other clinical trials. The study includes imaging with different radiotracers such as 68Ga-PSMA, 18F-FDG, or 18F-fluormisonidazole, with some participants returning for late imaging sessions 2 to 6 hours after radiotracer injection. During the study, participants will have PETCT imaging data collected to assess image quality over three years. Additional imaging techniques like breath-hold, dynamic, or delayed acquisitions may be used. Researchers will monitor image quality and pharmacokinetics of radiotracer uptake across disease sites. The total participation time depends on scheduled scans and follow-up imaging sessions.
CONDITIONS
Brief Title
A Study of a New PET Scanner in People With Cancer
Research Team
H
Heiko Schoder, MD
J
John Humm, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here